Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing sales7@sinochem-nanjing.com 3389378665@qq.com
Follow us:

6-Bromopyrido[2,3-D]Pyrimidin-4(1H)-One

    • Product Name 6-Bromopyrido[2,3-D]Pyrimidin-4(1H)-One
    • Alias 6-Bromo-pyrido[2,3-d]pyrimidin-4-one
    • Einecs 681-822-8
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry sales7@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    371235

    Chemical Name 6-Bromopyrido[2,3-D]Pyrimidin-4(1H)-One
    Cas Number 1201910-72-6
    Molecular Formula C7H4BrN3O
    Molecular Weight 226.03
    Appearance White to off-white powder
    Purity Typically ≥98%
    Smiles C1=CN=C2N=CN=C(C2=O)C1Br
    Inchikey KRQUMMLFCZANBA-UHFFFAOYSA-N
    Solubility DMSO, DMF, limited in water

    As an accredited 6-Bromopyrido[2,3-D]Pyrimidin-4(1H)-One factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing
    Shipping
    Storage
    Application of 6-Bromopyrido[2,3-D]Pyrimidin-4(1H)-One

    Applications of 6-Bromopyrido[2,3-D]Pyrimidin-4(1H)-One in Industrial Manufacturing

    6-Bromopyrido[2,3-D]pyrimidin-4(1H)-one plays an essential role as an advanced heterocycle building block for multiple high-value downstream sectors, especially where pyridopyrimidine scaffolds are required in regulated industrial synthesis. Below, we detail core application areas grounded in actual market adoption, supported by industry-recognized practices and integration protocols.

    1. Targeted Oncology Pharmaceutical Intermediates Production

    Pharmaceutical manufacturers incorporate this brominated heterocycle as a key starting intermediate during multi-step synthesis of small-molecule kinase inhibitors for oncology applications. Its pyrido[2,3-d]pyrimidinone core enables late-stage bromination-based coupling, supporting strict requirements on impurity profiling and batch-to-batch traceability under stringent GMP controls for active pharmaceutical ingredient (API) manufacturing pipelines targeting solid and hematological tumor indications.

    Industry compliance standards

    • ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
    • USP/NF Monographs for Intermediates (reference: custom synthesis protocols)
    • EU EudraLex Vol 4 GMP for APIs
    • FDA 21 CFR Part 211 (applicable stages)

    Typical usage ratio

    • 0.8 to 1.3 molar equivalents per final API batch, depending on active site requirements in intermediate coupling reactions

    Downstream process integration

    • Enters as a coupling partner in Buchwald-Hartwig or Suzuki-Miyaura cross-coupling after core pyrimidinone synthesis. Used at Stage 2 or 3 of API multi-step route, followed by deprotection and purification before final API formation.

    Final product types

    • Crude and purified small-molecule kinase inhibitor APIs
    • Advanced intermediates for clinical oncology compounds
    • Regulatory submission batches for Phase I–III trials

    2. Agrochemical Active Substance Synthesis

    Agrochemical companies apply the compound during the production of pre-emergence and post-emergence herbicide actives and insecticide lead candidates, especially those requiring a pyridopyrimidine core for selective mode-of-action compounds. The molecule is used at the pivotal heterocycle assembly stage, ensuring conformity with batch documentation and residual-bromine threshold specifications as outlined in regional plant protection product guidelines.

    Industry compliance standards

    • FAO Specifications for Plant Protection Products
    • OECD Principles of Good Laboratory Practice (GLP) for technical material synthesis
    • ISO 9001:2015 (production batches)
    • REACH Regulation (EC) No 1907/2006 (for EU)

    Typical usage ratio

    • 1.0 to 1.5 weight percent of core batch final mass, adjusted based on crop selectivity trials and pilot batch outcomes

    Downstream process integration

    • The compound feeds into the condensation step for target active ingredient synthesis, followed by derivatization (alkylation/amination) and formulation into technical concentrates.

    Final product types

    • Technical-grade herbicide actives
    • Insecticide R&D samples for regulatory dossiers
    • Analytical reference standards for formulation development

    3. Advanced Materials for Organic Electronics R&D

    High-purity lots of this heterocycle enter research-scale synthesis of donor-acceptor molecules serving as precursors for advanced organic field-effect transistors (OFETs) and thin-film transistor (TFT) prototypes. Materials science laboratories use this building block for constructing custom electronic architectures, where precise halogenation supports electrophilic substitution patterns necessary for charge-transport tuning.

    Industry compliance standards

    • ISO 14644-1 Cleanroom Standards (relevant for fabrication environments)
    • ASTM E2312-17 (performance standards for OFET materials)
    • Internal material purity specs (≥99.5% traceable to NMR/HPLC)

    Typical usage ratio

    • Varies from 0.2 to 0.6 mmol per 10 g synthesis batch, based on desired molecular weight and functional group content in final device

    Downstream process integration

    • Introduced at the small-molecule precursor synthesis stage, prior to functional group modification and polymerization or film casting. Used in gram-scale research lots.

    Final product types

    • Organic semiconductor intermediate batches
    • Prototype OFET substrates
    • Thin-film transistor test modules

    4. Custom Ligand Synthesis for Catalysis Development

    Catalyst innovators and contract labs employ this molecule in constructing N-donor and bifunctional ligand libraries for homogeneous transition metal catalysts, aiming at refining selectivity and turnover frequency in industrial processes such as hydrogenation and cross-coupling. Late-stage bromine provides anchor points for functional group diversification without introducing excess metal or organic residue, aiding controlled screening workflows under trace metal purity standards.

    Industry compliance standards

    • ISO 17025 (laboratory quality control, catalyst synthesis)
    • ACS Green Chemistry Institute Guidelines
    • Internal analytical standards for ligand trace metal analysis (ICP-OES)

    Typical usage ratio

    • 0.5 to 1.1 molar equivalents per ligand target preparation, based on intended coordination number and desired ligand framework complexity

    Downstream process integration

    • Used in early and mid-stage ligand design, introduced before complexation, followed by purification using flash chromatography or recrystallization to meet catalyst-grade purity

    Final product types

    • Homogeneous catalyst ligand reference samples
    • Research-scale catalyst precursor pools
    • Custom ligand libraries for screening automation platforms
    Free Quote

    Competitive 6-Bromopyrido[2,3-D]Pyrimidin-4(1H)-One prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to sales7@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: sales7@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    6-Bromopyrido[2,3-D]Pyrimidin-4(1H)-One: A Closer Look at Its Role in Today's Research

    Understanding the Significance of 6-Bromopyrido[2,3-D]Pyrimidin-4(1H)-One

    Each time I see 6-Bromopyrido[2,3-D]Pyrimidin-4(1H)-One mentioned in chemical literature or research project outlines, I remember the early days of my career in a busy academic lab. Back then, grad students often shared stories about the elusive “bridge” compounds – molecules tricky enough to slow down seasoned chemists but rewarding enough to spark genuine breakthroughs. As a pyridopyrimidinone, this molecule belongs to a class frequently found in new pharmaceutical investigations and materials innovation.

    Curiosity pushes scientists to find molecules that can nudge along discoveries. This compound’s structure sits right on the edge of familiar and novel. The addition of bromine at the sixth position delivers a unique twist to older, well-studied scaffolds. A key note in my own experimentation: halogen atoms like bromine can change how molecules interact inside a living cell or a catalytic reaction. When a chemist tackles 6-Bromopyrido[2,3-D]Pyrimidin-4(1H)-One, it’s not about using something generic. Deep interest comes from how a small group like bromine can open doors to unexplored reactions or boost the activity of known ones.

    The Specific Workhorse Model

    The structure of 6-Bromopyrido[2,3-D]Pyrimidin-4(1H)-One can be drawn as a fusion of two familiar rings, pyridine and pyrimidine, with an oxygen tucked onto the fourth position and that single bromine atom lined up at the sixth spot. This exact setup doesn’t pop up in everyday reagents. Old hands in organic synthesis will tell you – such subtle variations make all the difference. I remember working on a project where a shift from chlorine to bromine on a similar backbone gave us completely new biological results. In the context of synthetic medicinal chemistry, this molecule often becomes the heart of SAR – structure-activity relationship – studies, where each small shift in a scaffold’s layout is carefully logged.

    With molecular formula C7H4BrN3O, you’re working with a dense, layered framework that supports additional transformations. The slightly heavier bromine introduces unique NMR patterns and more pronounced mass spectra peaks. This helps in tracking progress during multi-step syntheses – a handy feature for researchers. In various formulations, white to off-white fine powder tends to be the most presentable form. My own preference in the lab leans toward the materials that avoid clumping and stay easy to weigh; this compound’s texture has never caused those old headaches associated with sticky or hygroscopic substances.

    Application in Real-World Research

    Let’s talk about what actually happens with a molecule like this. Modern research demands flexibility from reagents, whether someone is screening for a new kinase inhibitor, mapping out a library of analogs, or chasing down a jump in binding affinity. 6-Bromopyrido[2,3-D]Pyrimidin-4(1H)-One often lands in the “launchpad” category for medicinal chemistry. It acts as a building block, letting chemists slide on functional groups or stretch out rings, all while keeping the core pharmacophore intact.

    In my collaborations with drug discovery teams, the neat trick of brominated heterocycles emerges again and again. The bromine ring dials up the reactivity in cross-coupling reactions, such as Suzuki or Buchwald-Hartwig methods. Armed with palladium catalysts, researchers can tack on aryl, vinyl, or alkynyl groups, carving out space for vast analog libraries. Years ago, I observed a colleague shave six weeks off a project timeline by using a family of brominated intermediates, including this very core. That kind of speed matters when new threats emerge in the infectious disease world, or when a patent window tightens.

    What Sets 6-Bromopyrido[2,3-D]Pyrimidin-4(1H)-One Apart

    One of the chief selling points for this compound is the flexibility tied into its structure. If you’ve worked on a standard pyridopyrimidinone, you might know the pitfalls: limited points for further functionalization, sticky synthetic routes, or unstable intermediates. By comparison, adding bromine at the sixth position gives the compound a handhold for coupling chemistry that’s both robust and user-friendly. Looking at other halogenated relatives, some researchers lean on chloro- or fluoro-analogs, but bromine’s size and reactivity often strike a rare balance between stability and synthetic adaptability.

    Another story comes to mind from a partner lab a few years back: Two teams raced to build new kinase inhibitors, one leaning on a closely related chloro-derivative, the other sticking with bromine. The brominated team consistently pulled cleaner products and sidestepped problematic byproducts in cross-coupling reactions. As we pored over their NMR and LCMS traces, the trend was clear: The weight and size of bromine steered reactions in a slightly more forgiving way, opening up windows that their chloro cousins kept closed.

    Impact in Pharmaceutical and Chemical Discovery

    What does 6-Bromopyrido[2,3-D]Pyrimidin-4(1H)-One offer a modern lab? Think about the global challenge of finding new molecules that work against drug-resistant bacteria, emerging viruses, or rare diseases. Researchers need flexible backbones that help scaffold fragments or extend into unexplored chemical territory. The structure at the center of this compound gives teams an anchor to latch on innovation, not just repeat old chemistry.

    Practical work isn’t just about flexibility. Any synthetic chemist will talk about efficiency: high yields, clean reactions, and workable purification. I once ran a comparative synthesis using various halogenated pyridopyrimidinones and found that the brominated analog often crystallized out without fuss, cutting down time at the bench and minimizing solvent use. Multistep syntheses stack up rapidly in drug work, so any shortcut that protects both the yield and the sanity of a chemist is gold.

    Beyond pharmaceuticals, materials scientists have flagged these compounds for their stable electronic properties. Several research groups investigated 6-Bromopyrido[2,3-D]Pyrimidin-4(1H)-One as a core for organic electronics, dye chemistry, and even as a precursor for more exotic coupling reactions. Its planar structure and capacity for further functionalization open doors to dyes, sensors, and thin film applications. While the pharmaceutical world draws the most attention, the reach of this molecule extends into fields as far-flung as printable electronics and chemical sensing networks.

    Addressing Challenges in Sourcing and Use

    Access to high-quality intermediates always matters. Several years ago, a friend’s research faltered because their brominated intermediates arrived with too many impurities and suffered from poor batch-to-batch reproducibility. There’s a temptation to cut corners, but with finely tuned synthesis, the purity needs to stand up to scrutiny. Analytical methods such as HPLC, NMR, and LC-MS confirm that each batch of 6-Bromopyrido[2,3-D]Pyrimidin-4(1H)-One lives up to published standards. For sure, inconsistency can cost weeks of troubleshooting and lost funding, reminding us that reliable supply is as important as innovation.

    While price sometimes plays into the decision matrix, smart groups focus on value, not just cost. Saving a few dollars on a poorly vetted supply might lead to far greater losses during scale-up or final analysis. I’ve learned the hard way that cutting corners on intermediate quality can upend months of effort. Thus, collaborating with responsible suppliers who employ transparent documentation and batch testing remains a crucial practice.

    Safety, Handling, and Responsibility

    Responsible labs know the importance of handling reagents with care, especially those with halogen substitutions. I keep clear logs of every run involving this compound and use personal protective gear – gloves, eyewear, and good air flow – not because regulations demand it, but because experience has taught me that safety habits save lives. Halogenated intermediates sometimes trigger skin irritation or respiratory symptoms if handled in bulk or under poor ventilation. Rather than wait for a problem, seasoned researchers build a habit: weigh in the fume hood, use sealed containers, and keep cleanup materials at hand. These habits, repeated daily, set the standard for everyone on the team.

    Improving Science with Better Tools

    6-Bromopyrido[2,3-D]Pyrimidin-4(1H)-One’s presence in a chemical archive signals a lab’s readiness to explore or tackle hard-to-reach chemical space. One former mentor used to say good research grows from good foundations—reliable building blocks, thoughtful procedures, and an openness to follow promising leads. With this molecule, unique coupling chemistry, stable handling, and versatile ring structure combine to provide all three. I remember how a visiting scholar pulled out this compound at a group meeting, their voice rising as they described how it opened a pathway no other reagent allowed. That spark, both scientific and personal, marks the difference between checked-off boxes and actual discovery.

    Keeping up with new research, I often find applications for brominated pyrido[2,3-d]pyrimidinones in preclinical drug development, agrochemical exploration, and even as reference standards in chemical biology. Structurally related compounds have turned up in patents for kinase inhibitors, antiviral leads, and neuroprotective agents. The push for broader compound collections at both academic and commercial screening centers means molecules like this one are asked to perform in hundreds of biological assays, sometimes showing results where more obvious choices fail.

    Paving the Road for Future Research

    Not every scaffold offers both flexibility and proven track records. Some new molecular cores disappoint – reacting unpredictably, degrading in storage, refusing to crystallize or dissolve. Over the years, the best endorsements come from researchers who report real wins and fewer headaches during daily lab work. In discussions with chemists across the world, I’ve heard repeated praise for brominated pyridopyrimidinones, not just as one-off curiosities but as reliable building blocks for repeatable, creative synthesis.

    With access to 6-Bromopyrido[2,3-D]Pyrimidin-4(1H)-One, teams can branch out, test hypotheses faster, and iterate through analogs at a pace that matches the demands of funding cycles and publication deadlines. Newer variations on this core appear all the time—with elaborate side chains, fluorinated groups, or delicate substitutions. Yet, the presence of this single bromine atom at the sixth position becomes a pivot point for much of the successful chemistry I see today.

    Supporting Progress Through Education and Training

    Getting the most out of valuable building blocks doesn’t come automatically. I’ve worked with both experienced faculty and wide-eyed undergraduates; both groups benefit from strong training and a solid grounding in reaction strategy. Introducing students or younger colleagues to new intermediates usually starts with a frank walk-through of reactivity, risk, and potential. With 6-Bromopyrido[2,3-D]Pyrimidin-4(1H)-One, I’ll highlight optimal cross-coupling conditions, discuss solvent choices, and emphasize the importance of time management during each step. Surprises can happen, but careful planning and peer learning always stack the odds in your favor.

    Teaching moments also crop up around analytical techniques. Junior chemists sometimes underestimate the value of confirming identity and checking for impurities with TLC, NMR, or LC-MS. In my years around the benchtop, one missed impurity grew into a full month of repeat experiments. Now, reinforcing a protocol of “check every intermediate” means mistakes get caught early, and downstream processes run smoother. With this brominated pyrido[2,3-d]pyrimidinone, reliable characterization comes down to sharp peaks, clean baseline separations, and simple color recognition on TLC plates.

    Promoting Responsible Innovation and Collaboration

    One thing I’ve learned along the way: science depends on trust. Reaching out through professional forums, I’ve seen interdisciplinary teams push the frontier of what’s possible using shared tools and open protocols. Whether it’s an industry group working on oncology leads or an academic setting fueling the next round of SAR innovation, molecules like 6-Bromopyrido[2,3-D]Pyrimidin-4(1H)-One help to unite fields that don’t always speak the same language.

    Transparency about chemical sourcing, third-party batch analysis, and peer-reviewed case studies strengthen the foundation for tomorrow’s breakthroughs. Instead of hoarding knowledge or hiding errors, most successful organizations adopt a culture of open communication and continuous improvement. Knowing the quirks and strong points of intermediates, especially specialized ones like this, builds respect within a research team.

    Charting Tomorrow’s Course in Creative Synthesis

    The chemical industry and academia both chase solutions to real-world problems that affect daily life – whether it's public health, industrial sustainability, or novel materials. To make real progress, they need reagents that allow creative leaps. 6-Bromopyrido[2,3-D]Pyrimidin-4(1H)-One stands out because it gives scientists a dependable, flexible tool. Using this compound doesn’t guarantee discovery, but it shrinks the gap between idea and practical synthesis.

    Reflecting on projects past and present, my own success often came from blending trusted building blocks with new techniques, whether applying machine learning to reaction optimization or running scaled-up batch processes under continuous flow. Chemistry’s future rests on a bridge between tradition and disruption – and molecules like this one are the beams that hold it up.

    For the next generation of researchers, the appeal of 6-Bromopyrido[2,3-D]Pyrimidin-4(1H)-One goes beyond the odd elegance of its name. It’s about the confidence to test new hunches, design better experiments, and hand off a cleaner slate for the next wave of creative problem-solvers. In a field defined by both rigor and imagination, having an adaptable, well-characterized intermediate is a quiet advantage. I see science’s future every time I help a colleague or student discover that moment: the reaction runs as planned, the purity checks out, and new ideas shift from hope to result, all thanks to the thoughtful selection of the right molecular partner for the job.